AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Aprepitant in South Africa
8 products registered with SAHPRA — 8 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| APEMEZE 80 mg | 56/5.7.2/0062 | Eurolab (Pty) Ltd | active | 14 Nov 2028 |
| APEMEZE 125 mg | 56/5.7.2/0063 | Eurolab (Pty) Ltd | active | 14 Nov 2028 |
| VOMEND 80 | 53/5.7.2/0445 | Adcock Ingram Limited | active | 13 Jun 2028 |
| PREPIX 125 | 53/5.7.2/0449.446 | Adcock Ingram Limited | active | 13 Jun 2028 |
| VOMEND 125 | 53/5.7.2/0446 | Adcock Ingram Limited | active | 13 Jun 2028 |
| PREPIX 80 | 53/5.7.2/0448.445 | Adcock Ingram Limited | active | 13 Jun 2028 |
| EMEND 125 | A38/5.7.2/0627 | MSD (Pty) Ltd | active | 1 Jan 1900 |
| EMEND 80 | A38/5.7.2/0626 | MSD (Pty) Ltd | active | 1 Jan 1900 |
Aprepitant — SAHPRA Registration Details
SAHPRA (South Africa) has 8 registered products containing Aprepitant, of which 8 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Aprepitant registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.